Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000250286 | SCV000304536 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000710875 | SCV000841183 | benign | not provided | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000250286 | SCV000966284 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Gly1173Gly in exon 39 of COL4A5: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wi thin the splice consensus sequence, and has been identified in 12.25% (794/6480) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs61735627). |
Invitae | RCV000710875 | SCV001727462 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710875 | SCV001863018 | benign | not provided | 2018-12-18 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294119 | SCV002587454 | benign | Kidney disorder | 2021-11-16 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001274533 | SCV001458775 | benign | X-linked Alport syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000250286 | SCV001927226 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000710875 | SCV001952436 | likely benign | not provided | no assertion criteria provided | clinical testing |